Trial Profile
De novo combination therapy of adefovir plus lamivudine for the treatment of HBeAg-positive chronic hepatitis B in women of child-bearing age before pregnancy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 08 Dec 2015 New trial record